AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Novo Nordisk to open Type 1 diabetes R&D centre in Seattle.
(From Pharma)
M2PHARMA-January 24, 2012-Novo Nordisk to open Type 1 diabetes R&D centre in Seattle (C)2012 M2 COMMUNICATIONS http://www.m2.com
24 January 2012 - Danish Novo Nordisk A/S (CPH:NOVO B) said on Monday it plans to open a Type 1 diabetes R&D centre in Seattle, Washington.
Mads Krogsgaard Thomsen, Novo Nordisk executive vice president and chief science officer, said that with the new facility, the company hopes to speed up the process of finding new, innovative ways of treating diabetes.
The Novo Nordisk Type 1 Diabetes R&D Center will employ a translational research approach, combining basic research and early …
-
- THE BIOTECH INCOME OF NOVO NORDISK IS ESTIMATED TO HAVE GROWN BY 22.7% IN...
-
News wire article from: Asia Africa Intelligence Wire
June 30, 2005
700+ words
-
- California Hospital, Research Center's Suit against Biotech Firm Nears Jury.
-
News wire article from: San Jose Mercury News (San Jose, CA)
October 12, 2001
700+ words
-
- Seattle-Based ZymoGenetics Set to Go Public.
-
News wire article from: The Seattle Times (Seattle, WA)
January 28, 2002
700+ words
-
- Seattle's Oldest Biotechnology Firm Sells, Leases Back Headquarters.
-
News wire article from: The Seattle Times (Seattle, WA)
October 8, 2002
700+ words
-
- VCs take two bites out of Big Pharma.(venture capitalists invest in...
-
Newspaper article from: The Daily Deal
July 30, 2001
700+ words
